Justin Bowers
Stock Analyst at Deutsche Bank
(1.97)
# 3,024
Out of 5,176 analysts
40
Total ratings
39.13%
Success rate
4.58%
Average return
Main Sectors:
Stocks Rated by Justin Bowers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAT Waters | Maintains: Hold | $375 → $315 | $301.83 | +4.36% | 4 | Aug 5, 2025 | |
| MEDP Medpace Holdings | Maintains: Hold | $270 → $430 | $468.40 | -8.20% | 3 | Jul 23, 2025 | |
| IQV IQVIA Holdings | Maintains: Buy | $270 → $265 | $165.97 | +59.67% | 2 | Nov 1, 2024 | |
| FTRE Fortrea Holdings | Maintains: Hold | $28 → $23 | $9.44 | +143.64% | 3 | Aug 20, 2024 | |
| CON Concentra Group Holdings Parent | Initiates: Buy | $29 | $21.84 | +32.78% | 1 | Aug 19, 2024 | |
| TXG 10x Genomics | Downgrades: Hold | $55 → $25 | $20.78 | +20.31% | 3 | Jul 10, 2024 | |
| RGEN Repligen | Upgrades: Buy | $180 → $155 | $114.89 | +34.91% | 2 | Jun 26, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $600 → $610 | $488.73 | +24.81% | 3 | Apr 25, 2024 | |
| TECH Bio-Techne | Maintains: Buy | $85 → $82 | $52.72 | +55.54% | 2 | Apr 18, 2024 | |
| AVTR Avantor | Maintains: Hold | $23 → $25 | $7.61 | +228.52% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $17 | $3.13 | +444.00% | 3 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $280 → $300 | $100.74 | +197.80% | 2 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $310 → $275 | $186.82 | +47.20% | 2 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $250 | $246.68 | +1.35% | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $350 → $290 | $163.03 | +77.88% | 1 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $46 | $16.30 | +182.30% | 5 | May 10, 2021 |
Waters
Aug 5, 2025
Maintains: Hold
Price Target: $375 → $315
Current: $301.83
Upside: +4.36%
Medpace Holdings
Jul 23, 2025
Maintains: Hold
Price Target: $270 → $430
Current: $468.40
Upside: -8.20%
IQVIA Holdings
Nov 1, 2024
Maintains: Buy
Price Target: $270 → $265
Current: $165.97
Upside: +59.67%
Fortrea Holdings
Aug 20, 2024
Maintains: Hold
Price Target: $28 → $23
Current: $9.44
Upside: +143.64%
Concentra Group Holdings Parent
Aug 19, 2024
Initiates: Buy
Price Target: $29
Current: $21.84
Upside: +32.78%
10x Genomics
Jul 10, 2024
Downgrades: Hold
Price Target: $55 → $25
Current: $20.78
Upside: +20.31%
Repligen
Jun 26, 2024
Upgrades: Buy
Price Target: $180 → $155
Current: $114.89
Upside: +34.91%
Thermo Fisher Scientific
Apr 25, 2024
Maintains: Buy
Price Target: $600 → $610
Current: $488.73
Upside: +24.81%
Bio-Techne
Apr 18, 2024
Maintains: Buy
Price Target: $85 → $82
Current: $52.72
Upside: +55.54%
Avantor
Apr 18, 2024
Maintains: Hold
Price Target: $23 → $25
Current: $7.61
Upside: +228.52%
Aug 8, 2023
Maintains: Buy
Price Target: $23 → $17
Current: $3.13
Upside: +444.00%
Jul 14, 2023
Maintains: Buy
Price Target: $280 → $300
Current: $100.74
Upside: +197.80%
Apr 27, 2023
Maintains: Buy
Price Target: $310 → $275
Current: $186.82
Upside: +47.20%
Dec 14, 2022
Initiates: Hold
Price Target: $250
Current: $246.68
Upside: +1.35%
Jul 14, 2022
Maintains: Buy
Price Target: $350 → $290
Current: $163.03
Upside: +77.88%
May 10, 2021
Maintains: Buy
Price Target: $42 → $46
Current: $16.30
Upside: +182.30%